Ekso Bionics Inc.

NASDAQ: EKSO · Real-Time Price · USD
3.17
-0.02 (-0.63%)
At close: Aug 15, 2025, 12:24 PM

Ekso Bionics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.06M 3.38M 5.09M 4.13M 4.95M 3.76M 4.85M 4.61M 4.7M 4.12M 3.55M 3.33M 3.46M 2.57M 4.08M 3.05M 2.21M 1.91M
Cost of Revenue
1.24M 1.57M 2.38M 1.92M 2.31M 1.8M 2.48M 2.15M 2.45M 2.12M 1.87M 1.64M 1.82M 1.36M 1.66M 1.24M 919K 675K
Gross Profit
819K 1.81M 2.71M 2.21M 2.64M 1.95M 2.37M 2.46M 2.25M 2M 1.68M 1.69M 1.64M 1.21M 2.42M 1.81M 1.29M 1.24M
Operating Income
-3.98M -3.44M -2.23M -2.64M -2.33M -3.26M -3.45M -2.93M -4.28M -4.45M -4.44M -3.65M -3.23M -4.24M -4.55M -2.79M -3.35M -3.14M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-2.71M -2.89M -3.41M -2.07M -2.42M -3.43M -3.21M -3.37M -4.23M -4.39M -3.18M -4.3M -2.98M -4.62M -2.86M -1.96M -1.27M -3.67M
Net Income
-2.71M -2.89M -3.41M -2.07M -2.42M -3.43M -3.21M -3.37M -4.23M -4.2M -2.05M -4.95M -2.73M -5M -2.86M -1.96M -1.27M -3.67M
Selling & General & Admin
3.94M 4.26M 4.1M 4.07M 3.86M 4.07M 4.5M 4.23M 5.14M 5.29M 5.17M 4.4M 3.95M 4.45M 6.15M 3.98M 3.93M 3.77M
Research & Development
852K 988K 845K 777K 1.12M 1.14M 1.31M 1.16M 1.4M 1.15M 945K 936K 920K 999K 818K 618K 709K 603K
Other Expenses
n/a n/a n/a n/a n/a n/a -15K 3K -30K -5K -31K 4K -1K n/a n/a n/a n/a n/a
Operating Expenses
4.79M 5.25M 4.94M 4.85M 4.97M 5.21M 5.82M 5.39M 6.54M 6.45M 6.11M 5.34M 4.87M 5.45M 6.97M 4.6M 4.64M 4.37M
Interest Expense
-65K -72K 59K 79K 74K 57K 66K 64K 61K 112K 66K 34K 29K 27K 36K 24K 27K 26K
Selling & Marketing Expenses
1.69M 1.71M 1.88M 1.76M 1.85M 1.82M 1.98M 2.05M 2.35M 2.09M 1.95M 1.74M 1.84M 1.63M 2.04M 1.69M 1.79M 1.79M
Cost & Expenses
6.03M 6.82M 7.32M 6.77M 7.29M 7.01M 8.3M 7.54M 8.99M 8.57M 7.99M 6.98M 6.69M 6.8M 8.63M 5.84M 5.56M 5.05M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a 31K -191K -1.13M 650K -251K 383K n/a n/a n/a n/a
Shares Outstanding (Basic)
2.18M 25.39M 24.64M 20.31M 18.22M 17.42M 14.45M 14.07M 13.64M 13.3M 13.16M 13.07M 12.88M 12.73M 12.68M 12.66M 12.65M 10.75M
Shares Outstanding (Diluted)
2.18M 25.39M 24.64M 20.31M 18.22M 17.42M 14.45M 14.07M 13.64M 13.3M 13.16M 13.07M 12.88M 12.73M 12.68M 12.71M 12.74M 10.75M
EPS (Basic)
-1.24 -0.12 -0.14 -0.1 -0.13 -0.2 -0.22 -0.24 -0.31 -0.32 -0.16 -0.38 -0.21 -0.39 -0.23 -0.15 -0.1 -0.34
EPS (Diluted)
-1.24 -0.12 -0.14 -0.1 -0.13 -0.2 -0.22 -0.24 -0.31 -0.32 -0.16 -0.38 -0.21 -0.39 -0.23 -0.15 -0.1 -0.34
EBITDA
-3.98M -3.44M -2.96M -1.59M -1.95M -2.97M -2.47M -2.96M -3.9M -3.85M -2.86M -4.1M -2.62M -4.46M -2.7M -1.78M -1.1M -3.52M
EBIT
n/a -2.96M -3.35M -1.99M -2.34M -3.37M -3.15M -3.3M -4.17M -4.28M -3.11M -4.27M -2.95M -4.59M -2.83M -1.93M -1.25M -3.64M
Depreciation & Amortization
n/a -477K 398K 407K 397K 406K 675K 342K 267K 414K 255K 170K 331K 131K 130K 158K 147K 126K